# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001023024-25-000037
Filing Date
2025-04-10
Accepted
2025-04-10 16:40:20
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | anip_defa14ax04102025.htm | DEFA14A | 12016
2 | GRAPHIC | anipharmaceuticalsinc_vxna.jpg | GRAPHIC | 510591
3 | GRAPHIC | anipharmaceuticalsinc_vxnaa.jpg | GRAPHIC | 511416
| Complete submission text file | 0001023024-25-000037.txt |  | 1420339

Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31812 | Film No.: 25828916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)